Rockwell Medical (RMTI) investor relations material

Executive summary

• Net sales for Q2 2026 increased 11% year-over-year to $17.8 million, driven by new customer acquisitions, increased purchasing from existing customers, and pricing actions, while DaVita's share of sales declined.

• Gross profit for Q2 2026 was $3.2 million, a 30% increase year-over-year, with gross margin expanding to 18% due to lower manufacturing costs and higher volume.

• Net loss for Q2 2026 improved to $1.2 million from $1.5 million in Q2 2025 and $1.6 million in Q1 2026; basic and diluted net loss per share was $(0.34).

• Cash flow from operations was $2.1 million in Q2 2026, increasing the cash position to $24.8 million as of June 30, 2026.

• The company remains focused on executing its growth strategy, expanding profitability, and delivering long-term shareholder value.

Financial highlights

• Q2 2026 net sales: $17.8 million (up 11% YoY); six-month net sales: $35.1 million (flat YoY but up over 10% excluding DaVita).

• Q2 2026 gross profit: $3.2 million (+30% YoY); gross margin: 18% (up from 16% YoY); six months: $6.1 million (+11% YoY).

• Q2 2026 net loss: $1.2 million (improved from $1.5 million YoY and $1.6 million sequentially); six months: $2.8 million (improved from $3.0 million YoY).

• Adjusted EBITDA for Q2 2026: $(0.2) million (flat YoY); six months: $(0.4) million (improved from $(0.7) million YoY).

• Cash and equivalents at June 30, 2026: $24.8 million; total debt: $9.0 million.

Outlook and guidance

• 2026 annual guidance reiterated: net sales of $70–$75 million, gross margin of 18–22%, Adjusted EBITDA of $1–$2 million, and positive operating cash flow.

• Targeting annual net sales over $100 million and gross margins of ~30% by 2029, with annual profitability of $5–$10 million.

• Management believes current working capital is sufficient to meet operating requirements for at least the next twelve months.

• Focus remains on revenue growth, operational efficiencies, and sustained profitability.

• The company may raise additional capital via its $13.1 million ATM facility or other financing methods if needed.